Chronic osteomyelitis is difficult to be cured and often relapses, which presents to be a great challenge to clinicians. We conducted this original study to explore the efficiency of therapeutic alliance for chronic osteomyelitis by a multi-drug implant based on three-dimensional printing technology. We designed and fabricated preciously a multi-drug implant with a multi-layered concentric cylinder construction by three-dimensional (3D) printing technology. Levofloxacin and tobramycin were incorporated into the drug implant in a specific sequence. The drug release property of the drug implant was assayed in vitro. We also developed an animal model of chronic osteomyelitis to estimate the effect of the 3D printed multi-drug implant. The results showed that the multi-drug implant had a sustained and programmed drug release property. Levofloxacin and tobramycin which were released from the multi-drug implant worked in tandem to enhance pharmacodynamic action which was similar to a tumor chemotherapy program and were sufficient to treat chronic osteomyelitis. These findings imply that the administration of 3D printed multi-drug implant would be a potential therapeutic method for chronic osteomyelitis. Further studies are required.
MaderJTMohanDCalhounJ. A practical guide to the diagnosis and management of bone and joint infections. Drugs1997; 54: 253–264.
2.
LazzariniLMaderJTCalhounJH. Osteomyelitis in long bones. J Bone Joint Surg Am2004; 86-a: 2305–2318.
3.
PatzakisMJZalavrasCG. Chronic posttraumatic osteomyelitis and infected nonunion of the tibia: current management concepts. J Am Acad Orthop Surg2005; 13: 417–427.
4.
DaramolaJOAjagbeHA. Chronic osteomyelitis of the mandible in adults: a clinical study of 34 cases. Br J Oral Surg1982; 20: 58–62.
5.
HanssenAD. Local antibiotic delivery vehicles in the treatment of musculoskeletal infection. Clin Orthop Relat Res2005; 437: 91–96.
6.
MendelVSimanowskiHJScholzHC. Therapy with gentamicin-PMMA beads, gentamicin-collagen sponge, and cefazolin for experimental osteomyelitis due to Staphylococcus aureus in rats. Arch Orthop Trauma Surg2005; 125: 363–368.
7.
ChuTMOrtonDGHollisterSJ. Mechanical and in vivo performance of hydroxyapatite implants with controlled architectures. Biomaterials2002; 23: 1283–1293.
8.
CastroCSanchezEDelgadoA. Ciprofloxacin implants for bone infection. In vitro-in vivo characterization. J Control Release2003; 93: 341–354.
9.
van de BeltHNeutDUgesDR. Surface roughness, porosity and wettability of gentamicin-loaded bone cements and their antibiotic release. Biomaterials2000; 21: 1981–1987.
10.
JoostenUJoistAGoshegerG. Effectiveness of hydroxyapatite-vancomycin bone cement in the treatment of Staphylococcus aureus induced chronic osteomyelitis. Biomaterials2005; 26: 5251–5258.
11.
SultanaNWangM. Fabrication of HA/PHBV composite scaffolds through the emulsion freezing/freeze-drying process and characterisation of the scaffolds. J Mater Sci Mater Med2008; 19: 2555–2561.
12.
LiuSJWen-Neng UengS. A novel solvent-free method for the manufacture of biodegradable antibiotic-capsules for a long-term drug release using compression sintering and ultrasonic welding techniques. Biomaterials2005; 26: 4662–4669.
13.
UrsanIDChiuLPierceA. Three-dimensional drug printing: a structured review. J Am Pharm Assoc2013; 53: 136–144.
14.
YuDGBranford-WhiteCMaZH. Novel drug delivery devices for providing linear release profiles fabricated by 3DP. Int J Pharm2009; 370: 160–166.
15.
WuBMGiordanoRA. Solid free-form fabrication of drug delivery devicess. J Control Release1996; 40: 77–87.
16.
HuangWZhengQSunW. Levofloxacin implants with predefined microstructure fabricated by three-dimensional printing technique. Int J Pharm2007; 339: 33–38.
17.
WuWZhengQGuoX. The controlled-releasing drug implant based on the three dimensional printing technology: Fabrication and properties of drug releasing in vivo. J Wuhan Univ Technol-Mater Sci Ed2009; 24: 977–981.
18.
WuWZhengQGuoX. A programmed release multi-drug implant fabricated by three-dimensional printing technology for bone tuberculosis therapy. Biomed Mater2009; 4: 065005–065005.
19.
HuangWDZhengQXYangXL. Design and fabrication of drug delivery devices with complex architectures based on three-dimensional printing technique. Wuhan Univ Technol Mater Sci Ed2005; 20: 80–82.
20.
MatosACMarquesCFPintoRV. Novel doped calcium phosphate-PMMA bone cement composites as levofloxacin delivery systems. Int J Pharm2015; 490: 200–208.
21.
MartinBTucciMABenghuzziHA. In vitro evaluation of the effects of tobramycin and parathyroid hormone on mesenchymal stem cells. Biomed Sci Instrum2014; 50: 383–390.
22.
BastariKArshathMNgZH. A controlled release of antibiotics from calcium phosphate-coated poly(lactic-co-glycolic acid) particles and their in vitro efficacy against Staphylococcus aureus biofilm. J Mater Sci Mater Med2014; 25: 747–757.
23.
CicuendezMIzquierdo-BarbaIPortolesMT. Biocompatibility and levofloxacin delivery of mesoporous materials. Eur J Pharm Biopharm2013; 84: 115–124.
24.
YinLYManringMMCalhounJH. A rabbit osteomyelitis model to simulate multibacterial war wound infections. Mil Med2013; 178: 696–700.
25.
JiaWTFuQHuangWH. Comparison of borate bioactive glass and calcium sulfate as implants for the local delivery of teicoplanin in the treatment of methicillin-resistant staphylococcus aureus-induced osteomyelitis in a rabbit model. Antimicrob Agent Chemother2015; 59: 7571–7580.
26.
Cremieux AC, Saleh-Mghir A, Danel C, et al. alpha-Hemolysin, not Panton-Valentine leukocidin, impacts rabbit mortality from severe sepsis with methicillin-resistant Staphylococcus aureus osteomyelitis. J Infect Dis 2014; 209: 1773–1780.
27.
PigrauCAlmiranteBRodriguezD. Osteomyelitis of the jaw: resistance to clindamycin in patients with prior antibiotics exposure. Eur J Clin Microbiol Infect Dis2009; 28: 317–323.
28.
WhitenerCJParkSYBrowneFA. Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure. Clin Infect Dis2004; 38: 1049–1055.
29.
GerberJSCoffinSESmathersSA. Trends in the incidence of methicillin-resistant Staphylococcus aureus infection in children's hospitals in the United States. Clin Infect Dis2009; 49: 65–71.
30.
KlemmK. Gentamicin-PMMA-beads in treating bone and soft tissue infections. Zentralbl Chir1979; 104: 934–942.
31.
BakerADLMacnicolMF. Haematogenous osteomyelitis in children: epidemiology, classification, aetiology and treatment. Paediatr Child Health2008; 18: 75–84.
32.
ChangezMKoulVDindaAK. Efficacy of antibiotics-loaded interpenetrating network (IPNs) hydrogel based on poly(acrylic acid) and gelatin for treatment of experimental osteomyelitis: in vivo study. Biomaterials2005; 26: 2095–2104.
33.
JoostenUJoistAFrebelT. Evaluation of an in situ setting injectable calcium phosphate as a new carrier material for gentamicin in the treatment of chronic osteomyelitis: studies in vitro and in vivo. Biomaterials2004; 25: 4287–4295.
